Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of primary palmar hyperhidrosis
PACTR202006915898923Not yet recruiting
- Sponsor
- Mansoura University Faculty of Medicine
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of aluminum chloride and oxybutynin in primary palmar hyperhidrosis (PPH) (2 arms), sponsored by Mansoura University Faculty of Medicine. Primary endpoint: Hyperhidrosis Disease Severity Scale. Planned start May 2020; status: not yet recruiting.
02
Drugs
aluminum chlorideoxybutynin
03
Conditions
primary palmar hyperhidrosis (PPH)
Beyond the preview
Go deeper on PACTR202006915898923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006915898923.